SCHEMBL17599433

SCHEMBL17599433

CC(=O)Nc1cc(C(=O)O)cc(-c2cc(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)c3ccccc3c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ ALDH1A1 P00352 2/20 0.48
▸ HPGD P15428 2/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ CRHBP P24387 1/20 0.48
▸ CRHR2 Q13324 1/20 0.48
▸ PTGER4 P35408 2/20 0.41
▸ FABP1 P07148 1/20 0.40
▸ P2RY14 Q15391 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PFKFB3 Q16875 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KEAP1 Q14145 3/20 0.39
▸ NFE2L2 Q16236 1/20 0.39
▸ CREBBP Q92793 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599466 0.85 KMT2A (0.51) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599429 0.85 KMT2A (0.51) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599510 0.85 KMT2A (0.53) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599467 0.85 KMT2A (0.55) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599431 0.82 KMT2A (0.50) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599483 0.78 MEN1 (0.56) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599435 0.77 ALDH1A1 (0.57) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599423 0.77 ALDH1A1 (0.56) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599460 0.75 HPGD (0.51) KMT2AKDM4EMEN1ALDH1A1HPGD
SCHEMBL17599463 0.74 ALDH1A1 (0.57) KMT2AKDM4EMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback